ENVISION Overview
- Headquarters
- Frankfurt, De
- Website
- www.envision-icu.eu
- Industry
- Research Services
- Employees
- 31
- Founded
- 2021
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
About ENVISION
The course of the coronavirus disease can vary greatly, and knowledge about COVID-19 is still limited. Over 10% of patients of almost 60 million confirmed cases by November 2020, were admitted to hospitals’ Intensive Care Units (ICUs), which puts a considerable burden on medical staff. In the EU funded innovation project ENVISION, we want to use Artificial Intelligence (AI) to monitor and predict the course of the disease and support medical staff in treating patients timely and effectively. We will enforce an existing monitoring app that is already used in operating theatres with AI and collect and analyse data from hospitals in twelve different EU Member States. The intelligent new app will make the course of the disease more predictable and ease the burden of this pandemic on Europe’s medical staff. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101015930. All posts reflect the views of ENVISION only. http://envision-icu.eu/privacy-policy/
Compare Similar Companies to ENVISION
Swiss National Science Foundation SNSF
Research Services
Martel Innovate
It Services And It Consulting
Systems Biology Ireland
Biotechnology Research
Accelopment
Business Consulting And Services
COVend
Research
Precision Oncology Ireland
Research Services
BREAKthrough_DN
Research Services
Cresco Innovation
Research Services
ECHoS | Establishing of Cancer Mission Hubs: Networks and Synergies
Public Health